G1 Therapeutics, Inc. (GTHX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.1700 |
| Open | 4.1300 |
| Bid | 4.1000 x 400 |
| Ask | 4.1300 x 400 |
| Day's range | 3.9700 - 4.3050 |
| 52-week range | 1.0800 - 5.0000 |
| Volume | |
| Avg. volume | 1,336,785 |
| Market cap | 214.54M |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit
We feel now is a pretty good time to analyse G1 Therapeutics, Inc.'s ( NASDAQ:GTHX ) business as it appears the company...
- Insider Monkey
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1 Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.27. G1 Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
- Thomson Reuters StreetEvents
Q4 2023 G1 Therapeutics Inc Earnings Call
Q4 2023 G1 Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.